Presented ByProf. Thomas Powles, Barts Cancer Institute, UK
TrialPhase 3, KEYNOTE-361 ConferenceASCO 2024
TypePeer-reviewed article
18 July 2024 13:51
Presented ByProf. Matthew Galsky, Tisch Cancer Institute, NY, USA
TrialPhase 3, CheckMate 901 ConferenceASCO 2024
TypePeer-reviewed article
18 July 2024 13:48
Presented ByProf. Thomas Powles, Queen Mary University of London, UK
TrialPhase 3, EV-302/KEYNOTE-A39; CheckMate 901 ConferenceESMO 2023
TypePeer-reviewed article
19 December 2023 12:19
Presented ByDr Yohann Loriot, Gustave Roussy Cancer Institute, France
TrialPhase 3, THOR ConferenceASCO 2023
TypePeer-reviewed article
2 August 2023 09:20
Presented ByDr Enrico Grande, MD Anderson Cancer Center, Spain
TrialPhase 3, IMvigor130 ConferenceASCO 2023
TypePeer-reviewed article
2 August 2023 09:08
Presented ByProf. Robert Jones, University of Glasgow, UK
TrialPhase 2, ATLANTIS ConferenceASCO 2022
TypePeer-reviewed article
5 August 2022 14:11
Presented ByProf. James Catto, University of Sheffield, UK
TrialPhase 3, iROC ConferenceEAU 2022
TypeNews article
22 July 2022 12:30
Presented ByProf. Jürgen Gschwend, Technical University Munich, Germany
TrialPhase 3, IMvigor010 ConferenceEAU 2022
TypeNews article
22 July 2022 12:26
Presented ByDr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center, NY, USA
TrialPhase 2, BAYOU ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:19
Presented ByDr Simon Crabb, University of Southampton, UK
TrialPhase 2, ATLANTIS ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:18
Presented ByDr Sam Chang, Vanderbilt University Medical Center, TN, USA
TrialPhase 3, QUILT-3.032 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:18
Presented ByDr Yohann Loriot, Institut Gustave Roussy, France
TrialPhase 3, LEAP-011 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:18
Presented ByDr Francesca Vignani, Ordine Mauriziano Hospital, Italy
TrialPhase 2, Meet-URO12 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:17
Presented ByDr Roberto Iacovelli, Catholic University of Rome, Italy
TrialPhase 2, ARIES ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:17
Presented ByDr Wesley Yip, Memorial Sloan Kettering Cancer Center, NY, USA
TrialPhase 2 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:17
Presented ByProf. Marc-Oliver Grimm, University Hospital Jena, Germany
TrialPhase 2, TITAN-TCC ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:17
Presented ByDr Petros Grivas, University of Washington, WA, USA
TrialPhase 2, TROPHY-U-01 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:16
Presented ByProf. Daniel Petrylak, Yale School of Medicine, CT, USA
TrialPhase 1/2, EV-103 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:16
Presented ByDr Jeroen van Dorp, Netherlands Cancer Institute, the Netherlands
TrialPhase 1, NABUCCO ConferenceESMO 2021
TypePeer-reviewed article
19 November 2021 09:26
Presented ByDr Arjun Balar , Perlmutter Cancer Center, NY, USA
TrialPhase 1, INDUCE-1 ConferenceASCO 2021
TypePeer-reviewed article
12 August 2021 12:30
Presented ByDr. Thomas Powles, Barts Cancer Centre, London, UK
TrialPhase 3, EV-301 JournalPhysician’s Weekly ConferenceASCO GU 2021
15 April 2021 16:08
Presented ByDr Alison Birtle, Rosemere Cancer Centre, UK
TrialPhase 3, POUT ConferenceASCO GU 2021
TypePeer-reviewed article
24 March 2021 15:02
Presented ByDr Andrew Thomas Lenis, Memorial Sloan Kettering Cancer Centre, New York, USA
ConferenceASCO GU 2021
TypePeer-reviewed article
24 March 2021 15:02
Presented ByDr Marie Alt, Princess Margaret Cancer Centre, Canada
ConferenceASCO GU 2021
24 March 2021 15:02
TrialPhase 3, KEYNOTE-361 ConferenceESMO 2020
TypePeer-reviewed article
25 November 2020 14:43
ConferenceESMO 2020
TypePeer-reviewed article
25 November 2020 14:41
Presented ByDr Enrique Grande, MD Anderson Cancer Centre Madrid, Spain
TrialIMvigor130 ConferenceESMO 2019
TypePeer-reviewed article
26 November 2019 21:24
Presented ByDr Daniel P. Petrylak, Yale School of Medicine, USA
TrialEV-201, EV-301 ConferenceASCO 2019
TypePeer-reviewed article
15 July 2019 13:42